
北美给药市场预测至 2028 年 - COVID-19 影响和区域分析 - 按给药途径(注射给药、口服给药、经粘膜给药、局部给药、植入式给药和眼部给药)、分销渠道(医院药房、零售药房和在线药房)和最终用户(医院和诊所、家庭护理机构和其他最终用户)
No. of Pages: 233 | Report Code: BMIRE00028761 | Category: Life Sciences
No. of Pages: 233 | Report Code: BMIRE00028761 | Category: Life Sciences
根据疾病控制与预防中心 (CDC) 的数据,截至目前,美国约十分之六的人患有至少一种慢性病,而约十分之四的人患有两种或以上慢性病2019年,慢性病患者病情随时间恶化,给患者家庭和社会带来巨大负担。根据美国癌症协会 (ACS) 的预测,到 2023 年,美国可能会新增约 1,958,310 例癌症病例,并有 609,820 人死亡。糖尿病是一种危及生命的慢性疾病,没有专门的治疗方法。所有类型的糖尿病都会导致身体不同部位出现各种并发症,并增加过早死亡的风险。心脏病、中风、肾衰竭、截肢、视力丧失和神经损伤是与这种疾病相关的主要并发症。全球范围内,糖尿病病例显着增加。
慢性病患病率的增加促进了药物输送系统的更深入的研究和开发 (R&D)过去几十年。用于治疗慢性疾病的药物的治疗功效可以通过最佳的药物递送系统来提高,例如纳米颗粒(例如陶瓷、聚合物和金属)、胶束、脂质体和树枝状聚合物。通过药物递送系统施用药物还可以帮助减少药物的全身副作用。已经引入了各种药物递送载体,用于针对多种慢性疾病(如糖尿病、癌症、动脉粥样硬化、心肌缺血、哮喘、肺结核、帕金森病和阿尔茨海默病)进行靶向和受控的治疗。适当的药物输送系统可确保药物长期具有高生物利用度,从而增强任何药物的治疗功效。靶向药物递送系统(TDDS)以受控方式在受试者体内的预选部位释放药物。基于纳米技术的输送系统正在对癌症治疗产生重大影响,而聚合物在这些纳米颗粒载体的开发中发挥着关键作用。除了给药途径的多功能性之外,纳米治疗药物递送系统(NDDS)的一些值得注意的技术优势是延长半衰期、改善生物分布、增加药物循环时间、控制和持续药物释放以及提高细胞间药物浓度.
鉴于这些疾病的慢性性质,慢性病患者依赖持续的药物治疗,这与持续的副作用风险相关。开发合适的靶向药物递送系统可以促进靶向药物在致病病变中的积累,减少全身副作用,改善患者预后。因此,慢性病和生活方式疾病发病率的增加促进了北美给药系统市场的增长。
北美是最大的药物输送市场,其中美国占据最大的市场份额,其次是加拿大。北美市场增长的特点是生物制药和生物技术公司对罕见疾病药物的需求增加、主要市场参与者的存在以及各个学术和研究机构进行的广泛研发。此外,制药和生物技术公司的广泛研究预计将在预测期内支持北美药物输送市场的增长。
北美药物输送市场细分
北美药物输送市场根据给药途径、分销渠道、最终用户和国家/地区进行细分。< /span>
根据给药途径,北美给药市场分为注射给药、口服给药、经粘膜给药、局部给药、植入式给药、和眼部药物输送。 2023年,注射给药市场在北美给药市场中占据最大份额。
根据分销渠道,北美给药市场分为医院药房、零售药店和网上药店。 2023年,医院药房细分市场在北美给药市场中占据最大份额。
根据最终用户,北美给药市场分为医院和诊所、家庭护理机构和其他最终用户。 2023 年,医院和诊所在北美给药市场中占据最大份额。
根据国家/地区,北美给药市场分为美国、加拿大、墨西哥。 2023 年,美国在北美药物输送市场占据主导地位。
Bausch Health Companies Inc、Baxter International Inc.、Becton Dickinson and Co、勃林格殷格翰国际有限公司、波士顿科学公司、Gerresheimer AG、葛兰素史克公司、强生公司Johnson、Kindeva Drug Delivery LP、Novartis AG、Novo Nordisk AS、Pfizer Inc 和 Sever Pharma Solutions 是北美药物输送市场的领先公司。
Strategic insights for North America Drug Delivery involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 9,74,639.53 Million |
Market Size by 2028 | US$ 14,29,417.79 Million |
Global CAGR (2023 - 2028) | 8.0% |
Historical Data | 2021-2022 |
Forecast period | 2024-2028 |
Segments Covered |
By 给药途径
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Drug Delivery refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Drug Delivery Market is valued at US$ 9,74,639.53 Million in 2023, it is projected to reach US$ 14,29,417.79 Million by 2028.
As per our report North America Drug Delivery Market, the market size is valued at US$ 9,74,639.53 Million in 2023, projecting it to reach US$ 14,29,417.79 Million by 2028. This translates to a CAGR of approximately 8.0% during the forecast period.
The North America Drug Delivery Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Drug Delivery Market report:
The North America Drug Delivery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Drug Delivery Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Drug Delivery Market value chain can benefit from the information contained in a comprehensive market report.